FY results 2024

Positioned for strong growth

FY 2024 documents

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Expert views

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis

2 Apr 2025 - Alloc protecting group expanded the peptide synthesis toolbox – but its removal has been a problem: toxic solvents, air-sensitive Pd0) reagents, challenging upscaling. Not anymore A […]

Read more
Expert views

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase

20 Mar 2025 - Controlling impurities in complex drug substances is a crucial part of development and due to lack of harmonized approaches from Health authorities, the manufacturer faces many […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry